Schedule of Abbreviated New Drug Applications (ANDAs) – Exhibit 10.12

This document is a schedule listing various Abbreviated New Drug Applications (ANDAs), including their numbers, descriptions, and approval status. Most of the details are redacted, but it is clear that the schedule includes both approved and pending ANDAs. The document does not specify the parties involved or any obligations, but it appears to be an attachment or exhibit to a larger agreement, likely related to the transfer, licensing, or management of these ANDAs.